Invizyne Technologies (IZTC) Institutional Ownership $17.71 +0.32 (+1.84%) As of 02/21/2025 Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Invizyne Technologies (NASDAQ:IZTC)Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$767.73KNumber ofInstitutional Sellers(last 12 months)0 Get IZTC Insider Trade Alerts Want to know when executives and insiders are buying or selling Invizyne Technologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Invizyne Technologies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Citadel Advisors LLC27,652$456K0.0%N/A0.442% 2/17/2025 BNP Paribas Financial Markets2,113$35K0.0%N/A0.034% 2/12/2025 Geode Capital Management LLC16,764$277K0.0%N/A0.268% (Data available from 1/1/2016 forward) IZTC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IZTC shares? During the previous two years, the following institutional investors and hedge funds held shares of Invizyne Technologies shares: Citadel Advisors LLC ($456K), and Geode Capital Management LLC ($277K), BNP Paribas Financial Markets ($35K).Learn more on IZTC's institutional investors. Which institutional investors have been buying Invizyne Technologies stock? The following institutional investors have purchased Invizyne Technologies stock in the last 24 months: Citadel Advisors LLC ($27.65K), Geode Capital Management LLC ($16.76K), and BNP Paribas Financial Markets ($2.11K). How much institutional buying is happening at Invizyne Technologies? Institutional investors have bought a total of 46,529 shares in the last 24 months. This purchase volume represents approximately $767.73K in transactions. Related Companies KalVista Pharmaceuticals Major Shareholders ProKidney Major Shareholders ABIVAX Société Anonyme Major Shareholders Organogenesis Major Shareholders Compass Therapeutics Major Shareholders Akebia Therapeutics Major Shareholders PureTech Health Major Shareholders Altimmune Major Shareholders ChromaDex Major Shareholders Kamada Major Shareholders This page (NASDAQ:IZTC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invizyne Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Invizyne Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
